(RTTNews) - Glaukos Corp. (GKOS) on Wednesday reported three-year results from a Phase 3 extension study evaluating Epioxa, its epithelium-on corneal cross-linking therapy for keratoconus.
Chung toi hien cong khai y chinh. Tao tai khoan mien phi de doc toan bo bai viet, luu, thao luan va ket noi voi boi canh thi truong va OSINT.